We are proud to share the strong representation of the Translational Neuroscience Laboratory, led by A/Prof Richard Gordon, at the 7th
@World Parkinson Congress
#WPC2026 and the Planning for Prevention of Parkinsonās and Related Synucleinopathies: A Trial Design Forum, held in Phoenix, Arizona, this May.
š¬ Advancing Parkinsonās disease research through translational neuroscience
Three members of our team attended these important international scientific meetings: Jessika Suescun, MD, Senior Clinical Trial Manager; Sunil Srivastav, PhD, Postdoctoral Research Fellow; and Aishwarya Mary Johnson, MSc, PhD Candidate.
š International research engagement
Together, they received a total of AUD $11,400 in travel award support from
@Shake It Up Australia Foundation, enabling valuable participation, knowledge exchange, and international engagement across the Parkinsonās disease research community.
š Scientific contributions
Across both events, our laboratory presented 11 posters highlighting our ongoing translational research program in Parkinsonās disease and related synucleinopathies. The work spanned key areas including diagnostic approaches, disease progression biomarkers, drug repurposing strategies, preclinical therapeutic discovery, and novel disease-modifying molecular candidates.
š
Research recognition
We are especially proud that posters from two of our PhD candidates, Aishwarya Mary Johnson and Divya Onkar Mondhe, were selected for poster tours at the World Parkinson Congress. This recognition reflects the scientific quality, clinical relevance, and translational impact of their research contributions.
š Acknowledgements
We extend our sincere thanks to our current funding bodies, collaborators, and research supporters for their continued investment in Parkinsonās disease research:
@The Michael J. Fox Foundation for Parkinsonās Research
@Shake It Up Australia Foundation
@Wesley Research Institute
@U.S. Department of Defense
@QUT
@Translational Research Institute Australia
@PrincessAlexandraHospital
@UQCCR
š¤ Collaboration and impact
These meetings provided an outstanding opportunity to engage with researchers, clinicians, trialists, industry partners, advocates, and people with lived experience from around the world. The scientific discussions and collaborations formed are essential to advancing mechanistic understanding, biomarker development, therapeutic innovation, and clinical trial readiness in Parkinsonās disease and related neurodegenerative disorders.
We look forward to building on these connections as we continue working toward improved diagnostics, precision therapeutics, and disease-modifying strategies for people living with Parkinsonās disease.
#QUT #TRI #ParkinsonsDisease #ParkinsonsResearch #ParkinsonsAustralia #ParkinsonsAwareness #PDResearch #PDCommunity #Synucleinopathy #AlphaSynuclein #Neurodegeneration #MovementDisorders #TranslationalNeuroscience #TranslationalResearch #Neuroscience #ClinicalTrials #ClinicalTrialsAustralia #Biomarkers #DiseaseProgression #DrugRepurposing #DiseaseModifyingTherapies #Neurotherapeutics #PreclinicalResearch #MedicalResearch #HealthResearch #ResearchAustralia #AustralianResearch #QueenslandResearch #BrisbaneResearch #QueenslandHealth #MetroSouthHealth #PrincessAlexandraHospital #ShakeItUpAustralia #MJFF #WesleyResearch #WorldParkinsonCongress #WPC2026 #FightParkinsons #ParkinsonsQueensland #UQCCR